Birgit C Schultes
Evp, Chief Scientific Officer at Intellia Therapeutics, Inc. (NTLA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $79K